Skip to content

Quantitative study of cerebral blood flow and glucose metabolism in patients with internal carotid artery stenosis based on PET/MR

Quantitative study of cerebral blood flow and glucose metabolism in patients with internal carotid artery stenosis based on PET/MR

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099226
Enrollment
Unknown
Registered
2025-03-20
Start date
2024-09-03
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic cerebral ischemia

Interventions

Gold Standard:Arteriography findings
Index test:Hybrid PET/MR

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 50 patients with chronic unilateral ICA stenosis (subject to all of the following): 1. Angiography diagnosed unilateral anterior circulation head carotid artery stenosis, the diameter of the tube was reduced by >70%, and the contralateral anterior circulation and bilateral posterior circulation did not exceed the stenosis of >50% of the diameter reduction; 2. Must have had a transient ischemic attack or ischemic stroke within the lesion vascular area within the past 12 months, with the most recent onset being more than 3 weeks; 3. MRI showed no new infarct lesions in the skull; 4. There is no infarct lesion in the previous pontine area; 5. Any image of PET/MR blood flow and metabolic imaging shows decreased blood flow and metabolism in the hemisphere on the side of the lesion, and the reduction rate is more than 10% compared with that of the contralateral area; 6. Subjects and those in the know can complete relevant examinations and follow-ups; 7. Subjects or their authorized representatives sign the informed consent form. Enrollment criteria for the healthy control group: normal healthy people recruited in the neurosurgery clinic with gender and age matching the patient group, and no previous history of cerebral ischemia and other related diseases

Exclusion criteria

Exclusion criteria: 1. The image quality is not good due to head movement and other reasons during the scanning process; 2. Presence of other neurological diseases that can cause brain dysfunction (such as depression, brain tumor, Parkinson's disease, metabolic encephalopathy, encephalitis, multiple sclerosis, epilepsy, traumatic brain injury, normal intracranial pressure hydrocephalus, etc.); 3. Presence of other systemic diseases that can cause cognitive impairment, such as liver insufficiency, renal insufficiency, thyroid dysfunction, severe anemia, folic acid and vitamin B12 deficiency, special infections (such as syphilis, HIV), alcohol and drug abuse, etc.; 4. Presence of mental and neurodevelopmental retardation; 5. Presence of other diseases known to cause cognitive impairment; 6. Those who have severe visual and hearing impairment, claustrophobia, etc., and cannot cooperate with MRI examination; 7. Suffering from diseases that cannot cooperate with the completion of cognitive examinations; 8. Refusal to sign informed consent at baseline.

Design outcomes

Primary

MeasureTime frame
Cerebral blood flow;Glucose metabolism;Clincal score;

Countries

China

Contacts

Public ContactBixiao Cui

Xuanwu Hospital Capital Medical University

bixiao1311@163.com+86 10 83199428

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026